【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hypercholesterolemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hypercholesterolemia 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Hypercholesterolemia Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Hypercholesterolemia 38
Apr 01, 2014: Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese Study 38
Mar 30, 2014: Data From Phase 3 Pivotal Studies Show Amgen’s Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins 38
Mar 30, 2014: Evolocumab safely drops LDL cholesterol well below statin-only baseline 41
Mar 29, 2014: New Detailed Data from Three Phase 3 Pivotal Studies Show Amgen’s Novel Investigational Cholesterol-Lowering Medicine Evolocumab Significantly Reduced LDL Cholesterol By 55-66 Percent Compared To Placebo In Patients With High Cholesterol 42
Dec 19, 2013: Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab In Patients With High Cholesterol 44
Clinical Trial Profiles 46
Clinical Trial Overview of Top Companies 46
Merck & Co., Inc. 46
Clinical Trial Overview of Merck & Co., Inc. 46
AstraZeneca PLC 56
Clinical Trial Overview of AstraZeneca PLC 56
Sanofi 64
Clinical Trial Overview of Sanofi 64
Pfizer Inc. 69
Clinical Trial Overview of Pfizer Inc. 69
Regeneron Pharmaceuticals, Inc. 72
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 72
Aegerion Pharmaceuticals, Inc. 75
Clinical Trial Overview of Aegerion Pharmaceuticals, Inc. 75
Novartis AG 77
Clinical Trial Overview of Novartis AG 77
Kowa Company, Ltd. 79
Clinical Trial Overview of Kowa Company, Ltd. 79
Isis Pharmaceuticals, Inc. 81
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 81
Amgen Inc. 83
Clinical Trial Overview of Amgen Inc. 83
Clinical Trial Overview of Top Institutes / Government 85
National Heart, Lung, and Blood Institute 85
Clinical Trial Overview of National Heart, Lung, and Blood Institute 85
University of Manitoba 87
Clinical Trial Overview of University of Manitoba 87
Gachon University Gil Hospital 88
Clinical Trial Overview of Gachon University Gil Hospital 88
University of Pennsylvania 89
Clinical Trial Overview of University of Pennsylvania 89
University of Toronto 90
Clinical Trial Overview of University of Toronto 90
Osaka University 91
Clinical Trial Overview of Osaka University 91
University of Jena 92
Clinical Trial Overview of University of Jena 92
Maastricht University Medical Center 93
Clinical Trial Overview of Maastricht University Medical Center 93
Washington University School of Medicine 94
Clinical Trial Overview of Washington University School of Medicine 94
Monash University 95
Clinical Trial Overview of Monash University 95
Five Key Clinical Profiles 96
Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 202
【レポート販売概要】
■ タイトル：高コレステロール血症（Hypercholesterolemia）：グローバル臨床試験レビュー（2014年上半期）■ 英文：Hypercholesterolemia Global Clinical Trials Review, H1, 2014
■ 発行日：2014年4月30日
■ 調査会社：GlobalData
■ 商品コード：GDHC2116CTIDB
■ 調査対象地域：グローバル
- キーストローク生体認証の世界市場2016-2020About Keystroke Biometrics Keystroke biometric technology uses two methods for verification of individuals: static and dynamic. Static keystroke biometric technology analyzes the characteristics of an end-user’s keystroke patterns only at specific times, such as during the login process. Dynamic keystroke biometrics provides continuous verification of an end-user throughout the time period of his …
- 食物繊維の世界市場：不溶性食物繊維、可溶性食物繊維About Dietary Fiber Dietary fibers are long thread-like structures that are widely present in fruits, vegetables, and grains. They are also known as roughage or bulk and include all parts of plant foods that are not digested or absorbed by the body. Though indigestible, they prove to be extremely useful in maintaining bowel regularity and preventing constipation and other bowel abnormalities. Tech …
- 原子層堆積（ALD）法の世界市場：タイプ別（フィルム、プリカーサ、材料、その他）、製品タイプ別（酸化アルミニウムALD、触媒ALD、金属ALD、プラズマ使用ALD、その他）、用途別、最終用途別（半導体・電子、化学 、エネルギー、その他）、地域別予測Global Atomic Layer Deposition (ALD) Market to reach USD 3.1 billion by 2025. Global Atomic Layer Deposition (ALD) Market valued approximately USD 1.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 12.04% over the forecast period 2017-2025. Increasing need for miniaturized components and Nano-technology, advancement in electronic sectors, increasing concern for glob …
- 女性の性的欲求低下障害(Female Hypoactive Sexual Desire Disorder)の治療薬パイプライン動向（2015年上半期版）Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015’, provides an overview of the Female Hypoactive Sexual Desire Disorder’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete wi …
- 衛星M2M通信及びサービスの世界市場2015-2019About Satellite M2M Connections and Services Satellite M2M technology enables the communication of data and information among electronic devices with the help of satellite networks. Satellites communication provides a huge opportunity for the M2M industry. Terrestrial networks covers only 10% of the world and the remaining is covered via satellite networks. With end-users demanding high-speed and …
- 世界の豊胸手術市場動向：Global Breast Implants Market 2014-2018TechNavio forecasts The Global Breast Implants Market with a CAGR of 6.08 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provide the …
- 自動車用ハロゲンヘッドライトの世界市場2019-2023About this market Halogen bulbs are the most economical option for the headlights in automotive vehicles. They are not only cost-effective but are also long-lasting enough to justify their pricing. Halogen reflectors are the most basic type of headlights which are standardly adopted by mini vehicles across the world. In addition, to significantly lower the cost of production of halogen headlights, …
- イソシアネート（Isocyanate）の世界市場（～2019）Isocyanates are used to make various products, ranging from flexible or rigid lightweight foams to tough, stiff, and strong elastomers. This enables their use in variety of consumer and industrial applications. Some of the examples are thermal insulation of buildings, refrigerators, household furniture, automotive seating, packaging, cushioning, shoe soles. The major application of isocyanate is r …
- Location as a Service (LaaS)Location as a Service is a complex derivative of the cloud services concept while being a natural business extension for corporations that have built their operating foundations on GIS, mapping, and navigation. Additionally, a great number of small companies are enabling Location as a Service (LaaS). Why are they jumping in full-force with VC backing and what are the challenges they will endure? W …
- 水性エポキシ樹脂の世界市場：用途、需要先、地域別分析Waterborne epoxy resins exhibit high stability and excellent dilution efficiency. The waterborne epoxy resins offer different functionalities for a variety of applications such as automotive, construction, textiles, furniture and packaging. The aqueous epoxy resins include non-ionic epoxy-functional emulsifiers, which allow the emulsifier to become a part of the cured product with minimal impact o …
- 世界のスナックペレット食品市場（～2019）Snack pellets are semi-finished expandable snack that are manufactured using extrusion process. These are available in multiple forms, shapes, flavors, and textures. Hot air expansion and hot oil frying are two of the most commonly used methods for the conversion of snack pellets into finished ready-to-eat form. Conversion of snack pellets using hot air is considered to be healthy as it avoids the …
- 世界の溶媒市場動向と予測（～2018）Solvent find their usage in various industries for one or more applications. It is used as a carrier to dissolve pigments and other ingredients, as well as to enhance certain properties such as the density of solutions. The major application is paints and coatings, which accounts for a majority of the solvents usage, followed by the pharma industry, adhesives, cleaning of metals, printing inks, pe …
- 電力産業向けバルブの世界市場2016-2020About Valves Valves are devices that are used to control, direct, and regulate the flow and pressure of gases, liquids, and fluidized solids. Globe valves, gate valves, butterfly valves, ball valves, and safety relief valves among others are used in various process industries such as oil and gas, chemical, power, refining, and food and beverage. These valves can be operated electrically, pneumatic …
- 保険産業向けソフトウェアの世界市場2016-2020About Insurance Software The global insurance industry is a potential market for technology providers. The increased expenditure on technology by the insurance sector has moved the focus on productivity and efficiency, and has brought in a wide range of challenges to insurers. The uncertainty in financial markets, changing consumer demands, and digitally savvy new competitors have emerged as new c …
- プラスチック・パッケージング（包装材料）の世界市場About Plastic Packaging Plastic packaging is used for packaging F&B, pharmaceuticals, chemicals, and other consumer products. Plastic bottles and containers are non-corrosive, light, and relatively cheap. Also, plastic can be molded into a variety of shapes and dimensions, making it highly suitable for packaging. Its inert nature and ability to preserve products for a long period of time makes it …
